An organization as advanced as ChemImage makes news on many fronts, and within many industries. Feel free to browse the source news releases that launched a number of well-placed (well-received) stories in pharmaceutical, biomedical, anti-terror, and forensic journals and publications.
December 23rd, 2009
ChemImage Corporation Selected for $2 Million Defense Funding
Pittsburgh, PA (ChemImage Corporation) December 23, 2009 – ChemImage Corporation was selected for $2 Million in defense funding for the further development of Eye-Safe Stand-off Fusion Detection of chemical, biological, explosive and improvised explosive device threats. The funding for this contract comes as a part of the Fiscal Year 2010 Defense Appropriations Act that was approved by Congress and signed by the President this past weekend. Primary sponsorship for the funding came from U.S. Congressman Mike Doyle with Senate support from both Senators Arlen Specter and Bob Casey.
|
 |
December 17th, 2009
ChemImage’s Dr. Patrick Treado Honored with the
2010 Williams-Wright Award at PittCon
Pittsburgh, PA (ChemImage Corporation) December 17th, 2009 – ChemImage Corporation is proud to announce Dr. Patrick J. Treado, Founder and Chief Technology Officer, will be presented with the Coblentz Society’s Williams-Wright Award at The Pittsburgh Conference (PittCon) and Expo 2010 (February 28th – March 5th, Orlando, FL). The Williams-Wright Award is presented annually to an industrial spectroscopist who has made significant contributions to vibrational spectroscopy while working in industry.
|
|
November 18th, 2009
Improving Quality, Cost-Effectiveness, and Time Savings in Preclinical Inhalable Formulation Development
Pittsburgh, PA (ChemImage Corporation) November 18th, 2009 - In today’s fast growing inhalables market, the availability of suitable, efficient and cost-effective means of gathering particle analysis data for pulmonary formulation is clear. At this year’s Drug Delivery to the Lungs 20 (DDL 20) meeting, experts from ChemImage Corporation, will be on hand to discuss our patented chemical imaging technology and how ingredient-specific particle sizing (ISPS) fulfils precisely this requirement for drug particle size data. |
|
October 6th, 2009
ChemImage to Present on Hyperspectral Imaging for Questioned Document Examination at IMI’s 6th Annual Security Printing Conference
Pittsburgh, PA (ChemImage Corporation) October 6th, 2009 – ChemImage announces that it will give a
presentation on hyperspectral imaging for Questioned Document Examination at IMI’s 6th Annual Security
Printing Conference. The conference, being held at the Sheraton Baltimore City Center Hotel in
Baltimore, Maryland, USA, runs from November 16-18, 2009 and is sponsored by Information
Management Institute (IMI). Complete conference details can be found at www.imiconf.com.
|
|
October 5th, 2009
ChemImage Advancing Hyperspectral Imaging Technology at FACSS 2009
Pittsburgh, PA (ChemImage Corporation) October 5th, 2009 – ChemImage, a leader in Chemical Imaging technology, is pleased to announce our continuing support of the spectroscopy community at this year's Federation of Chemical and Spectroscopy Societies (FACSS) 2009 annual meeting (October 18 – 22nd, Louisville, Kentucky). Representatives from ChemImage will be offering workshops as well as reporting on current developments within the threat and pharmaceutical markets of hyperspectral imaging applications and instrumentation.
|
|
October 2nd, 2009
ChemImage Corporation Ranked 34th in the Electronics & Instruments Patent Scorecard™
Pittsburgh, PA (ChemImage Corporation) October 2nd, 2009 – ChemImage, a world leader in molecular
chemical imaging technologies, has been ranked 34th in the United States for Technology Strength™
according to The Patent Board’s Electronics & Instruments Patent Scorecard™ published in The Wall
Street Journal Market Data Center earlier this week. |
|
September 21st, 2009
CHEMIMAGE WEB SITE WINS THE 2009 BEST IN INDUSTRY WEB AWARD FOR SCIENCE STANDARD OF EXCELLENCE
Pittsburgh, PA (ChemImage Corporation) September 21, 2009 - ChemImage, a leader in hyperspectral and chemical imaging technology, is pleased to announce that the Web Marketing Association has awarded ChemImage’s web site with the 2009 Web Award for Best of Industry in Science Standard of Excellence. |
|
August 11th, 2009
CHEMIMAGE UNVEILS THE NEW HSI EXAMINER 100 QD SYSTEM FOR FORENSIC QUESTIONED DOCUMENT EXAMINATION
ChemImage, a leader in hyperspectral and chemical imaging technology, is pleased to announce the release of the HSI Examiner 100 QD for examination of questioned documents. This product is being released at the American Society of Questioned Document Examiners 2009 Annual Meeting on August 11th, 2009 in Dearborn, Michigan |
|
July 20th, 2009
CHEMIMAGE ANNOUNCES RELEASE OF LOWER COST FALCON II™ WIDE-FIELD RAMAN CHEMICAL IMAGING PLATFORMS
New Editions of the FALCON II Wide-Field Raman Chemical Imaging System to provide an economic option for pharmaceutical organizations seeking to obtain more accurate drug particle size distribution measurements. |
|
June 3rd, 2009
CHEMIMAGE WORKS TO IMPROVE EXISTING METHODS OF IMAGING UNTREATED FINGERPRINTS ON PAPER SUBSTRATES
Scientists at ChemImage are pleased to report significant improvements in the ability to enhance contrast of untreated fingerprints on paper substrates. Using the CONDOR™ Hyperspectral Imaging System, application scientists at ChemImage have been able to apply new developments in software and hardware configurations resulting in the enhancement of more ridge detail of untreated latent prints on paper. |
|
May 6th, 2009
RDD EUROPE 2009 PLAYS HOST TO CHEMIMAGE’S ADVANCED INGREDIENT-SPECIFIC
PARTICLE SIZING™ TECHNOLOGY
Representatives from pharmaceutical companies developing nasal and pulmonary drug delivery systems who are attending RDD Europe 2009, May 19-22, in Lisbon, Portugal, can get a better look at how ChemImage’s Wide-Field Raman Chemical Imaging technology can help them develop new drug products with greater speed and accuracy of drug particle size distribution measurements. |
|
April 1st, 2009
CHEMIMAGE AND NEXT BREATH STRUCTURE PARTNERSHIP TO VALIDATE BIOEQUIVALENCE TESTING FOR NASAL SPRAY SUSPENSIONS
ChemImage, today announces a strategic research partnership with Next Breath, LLC, a leading Contract Research Organization (CRO) to further validate ChemImage’s Raman Chemical Imaging for bioequivalence applications for nasal spray suspensions. |
|
March 16th, 2009
CHEMIMAGE SIGNS AGREEMENT WITH SHENZHEN FORENSIC SCIENCE & TECHNOLOGY TO DISTRIBUTE HYPERSPECTRAL IMAGING PRODUCTS IN CHINA
ChemImage’s hyperspectral imaging technology is now available to forensic scientists and law enforcement officials in China thanks to a distribution agreement with Shenzhen Forensic Science & Technology Co., Ltd. |
|
February 25th, 2009
GENERIC DRUG MAKERS SEEKING “FIRST-TO-FILE” STATUS WITH FDA CAN NOW UTILIZE EMERGING BIOEQUIVALENCE TECHNOLOGY
ChemImage’s Wide-Field Raman Chemical Imaging Technology Enables Generics to Obtain Drug-specific Particle Sizing, Offers First-to-Market Opportunity for Nasal Spray Suspensions. |
|
February 2nd, 2009
Pace of Solving Crimes Accelerated with Hyperspectral Imaging Technology
Today, ChemImage one of the world’s leading chemical and biological imaging technology solutions companies, is helping law enforcement and forensic scientists increase their ability to solve crimes via the CONDOR™ Hyperspectral Imaging System, which is more accurate than any other forensic imaging instrumentation on the market – particularly those involving blood splatter, latent prints and questioned documents. |